CENTER FOR HIGH-THROUGHPUT MINIMALLY-INVASIVE DOSIMETRY
Project Number3U19AI067773-05S1
Contact PI/Project LeaderBRENNER, DAVID JONATHAN
Awardee OrganizationCOLUMBIA UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
Our overall theme is product development for very high throughput minimally-invasive radiation biodosimetry. After a large-scale radiological event, there will be a major need to assess, within a few days, the radiation doses received by tens of thousands of individuals. By contrast, current "high throughput" biodosimetry can, at best, assess a few hundred individuals / day. We will develop practical minimally-invasive devices to meet this need, capable of assessing tens of thousands of individuals per day. The Consortium represents a multidisciplinary balance between radiation biologists, radiation physicists, radiation chemists, mechanical engineers, software engineers, product development experts, commercial companies in the field, and end users. The three areas that we have identified as having the highest potential for high-throughput biodosimetry are cytogenetics, functional genomics, and metabolomics; each area has its own project, supported by a bioinformatics core, a functional genomics core, a fabrication core and, crucially, a product development core. The three projects are linked in terms of the overall theme, their use of the Core Resources, and also in terms of their shared use of the same sources of human samples - blood/urine/buccal cells from total-body irradiated patients:
Project 1: Automated Robotically-Based High-Throughput Radiation Biodosimetry - We will develop a high-throughput biodosimetry device, using purpose-built robotics and advanced high speed, automated image acquisition. Throughput will reach 30,000 samples per day, compared with current throughputs of a few hundred samples per day. Several endpoints (micronuclei and y-H2AX foci) and several tissues (blood lymphocytes, reticuloctyes, and exfoliated cells from urine) can be used.
Project 2: Biodosimetry with a Fully Integrated Biochip using Gene Expression Signatures - Exposure to ionizing radiation produces a well-defined dose-dependent signature in terms of changes in gene expression. Our goal is to use such a signature, which will be established through the Functional Genomics Core, to generate a self-contained radiation biodosimeter device, based on a blood finger stick.
Project 3: Rapid Non-Invasive Radiation Biodosimetry through Metabolomics - Here the overall aim is to identify and utilize a signature of radiation exposure through metabolomics, in order to develop a very fast non-invasive biodosimetric device based on urine, saliva or sweat.
In addition, this Consortium features an extensive radiological teaching program, both in person, and with an innovative E-seminars approach, and a large Pilot Research Program, featuring a novel two-phase review procedure.
National Institute of Allergy and Infectious Diseases
CFDA Code
701
DUNS Number
621889815
UEI
QHF5ZZ114M72
Project Start Date
22-September-2009
Project End Date
31-August-2011
Budget Start Date
22-September-2009
Budget End Date
31-August-2011
Project Funding Information for 2009
Total Funding
$399,999
Direct Costs
$249,659
Indirect Costs
$150,340
Year
Funding IC
FY Total Cost by IC
2009
National Institute of Allergy and Infectious Diseases
$399,999
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3U19AI067773-05S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U19AI067773-05S1
Patents
No Patents information available for 3U19AI067773-05S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U19AI067773-05S1
Clinical Studies
No Clinical Studies information available for 3U19AI067773-05S1
News and More
Related News Releases
No news release information available for 3U19AI067773-05S1
History
No Historical information available for 3U19AI067773-05S1
Similar Projects
No Similar Projects information available for 3U19AI067773-05S1